Eeyarestatin I inhibits Sec61-mediated protein translocation at the endoplasmic reticulum
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Production and trafficking of proteins entering the secretory pathway of eukaryotic cells is coordinated at the endoplasmic reticulum (ER) in a process that begins with protein translocation via the membrane-embedded ER translocon. The same complex is also responsible for the co-translational integration of membrane proteins and orchestrates polypeptide modifications that are often essential for protein function. We now show that the previously identified inhibitor of ER-associated degradation (ERAD) eeyarestatin 1 (ESI) is a potent inhibitor of protein translocation. We have characterised this inhibition of ER translocation both in vivo and in vitro, and provide evidence that ESI targets a component of the Sec61 complex that forms the membrane pore of the ER translocon. Further analyses show that ESI acts by preventing the transfer of the nascent polypeptide from the co-translational targeting machinery to the Sec61 complex. These results identify a novel effect of ESI, and suggest that the drug can modulate canonical protein transport from the cytosol into the mammalian ER both in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495 · cited 1×
“Subtle modulation of protein homeostasis in diseased cells, for example using small molecule inhibitors, is a promising strategy for therapeutic intervention (Balch et al., 2008).”
BackgroundProtein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes.
Rapoport, T. A. (2007) · Nature · doi:10.1038/nature06384 · Cited by 977 · cited 3×
“When active, the ER translocon appears highly dynamic and is likely to exist as a dimer of Sec61-- complexes (Rapoport, 2007) together with accessory proteins required for co-translocational processing of nascent polypeptide chains (Hegde and Kang, 2008).”
BackgroundDistinct modes of signal recognition particle interaction with the ribosome.
Pool, M. R., Stumm, J., Fulga, T. A., Sinning, I., & Dobberstein, B. (2002) · Science · doi:10.1126/science.1072366 · Cited by 199 · cited 3×
“Cross-linking analysis of SRP54 was performed as described elsewhere (Pool et al., 2002).”
BackgroundMethodSelf-citationErdmann, F., Jung, M., Eyrisch, S., Lang, S., Helms, V., Wagner, R., & Zimmermann, R. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.06.032 · Cited by 20
Cited by
Endoplasmic Reticulum and the Unfolded Protein Response
(2013) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-407704-1.00005-1 · Cited by 548
Pharmacological targeting of endoplasmic reticulum stress in disease
Marciniak, S. J., Chambers, J. E., & Ron, D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00320-3 · Cited by 520
Deubiquitinase inhibition as a cancer therapeutic strategy
D'Arcy, P., Wang, X., & Linder, S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.002 · Cited by 310
Hall, B. S., Hill, K., McKenna, M., Ogbechi, J., High, S., Willis, A. E., & Simmonds, R. E. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004061 · Cited by 162
“Membranes were recovered as described [31] by centrifugation through 750 mM sucrose, 500 mM KOAc, 5 mM Mg(OAc)2, 50 mM HEPES-KOH (pH 7.”
BackgroundMethodSelf-citationIpomoeassin F Binds Sec61α to Inhibit Protein Translocation
Zong, G., Hu, Z., O’Keefe, S., Tranter, D., Iannotti, M. J., Baron, L., Hall, B., Corfield, K., Paatero, A. O., Henderson, M. J., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13506 · Cited by 93
Self-citationOswald, J., Njenga, R., Natriashvili, A., Sarmah, P., & Koch, H.-G. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.664241 · Cited by 88
Co-translational protein targeting in bacteria.
Steinberg, R., Knüpffer, L., Origi, A., Asti, R., & Koch, H.-G. (2018) · FEMS Microbiology Letters · doi:10.1093/femsle/fny095 · Cited by 81
Decatransin, a novel natural product inhibiting protein translocation at the Sec61/SecY translocon
Junne, T., Wong, J., Studer, C., Aust, T., Bauer, B. W., Beibel, M., Bhullar, B., Bruccoleri, R., Eichenberger, J., Estoppey, D., et al. (2015) · Journal of Cell Science · doi:10.1242/jcs.165746 · Cited by 67
“likely binding to the translocon and preventing the transfer of the nascent-chain–ribosome complex from the SRP–SRP receptor targeting complex to the translocon in mammalian cells (Cross et al., 2009).”
BackgroundGamayun, I., O'Keefe, S., Pick, T., Klein, M.-C., Nguyen, D., McKibbin, C., Piacenti, M., Williams, H. M., Flitsch, S. L., Whitehead, R. C., et al. (2019) · Cell Chemical Biology · doi:10.1016/j.chembiol.2019.01.010 · Cited by 51
Self-citationSteenhuis, M., Koningstein, G. M., Oswald, J., Pick, T., O’Keefe, S., Koch, H., Cavalié, A., Whitehead, R. C., Swanton, E., High, S., et al. (2021) · Molecular Microbiology · doi:10.1111/mmi.14589 · Cited by 11
Self-citation
Metadata
- Authors
- Cross, B. C. S., McKibbin, C., Callan, A. C., Roboti, P., Piacenti, M., Rabu, C., Wilson, C. M., Whitehead, R., Flitsch, S. L., Pool, M. R., High, S., & Swanton, E.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2009-12-01
- Volume
- 122
- Issue
- 23
- Pages
- 4393-4400
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2129574945
- Cited by
- 109
- References
- 4
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.